Refine by
Pharmacokinetic Articles & Analysis
158 news found
These precision-engineered compounds are widely used in PEGylation, a process that enhances the pharmacokinetics and stability of therapeutic molecules. They are also critical components in antibody-drug conjugate (ADC) linkers, facilitating targeted drug delivery, and in PROTAC linkers, enabling the development of novel protein degradation therapies. ...
The AI-powered system evaluates important characteristics, such as binding affinity and pharmacokinetics, to refine compounds and enhance their therapeutic potential. ...
CD Formulation’s dedication to precision and innovation extends to the development of Antibody Oligonucleotide Conjugates (AOCs), which harness antibodies for the selective delivery of therapeutic oligonucleotides, improving pharmacokinetic profiles and expanding drug applicability. Through continuous enhancement of their services, CD Formulation reaffirms its commitment to ...
Movantik, featuring an m-PEG7 linker, exemplifies the significant advantages of monodisperse PEGylation, resulting in improved solubility, bioavailability, and pharmacokinetics compared to traditional approaches. Asclera (Polidocanol) is another notable example, incorporating an m-PEG9 entity that can function as a local anesthetic in topical ointments or as an injectable ...
By leveraging its expertise and resources, the company can develop animal models, cell models, multicellular models, pharmacokinetic/pharmacodynamic modeling, biomarker discovery, and more. These model development services are designed to offer researchers the tools and resources they need to optimize drug development and maximize success rates. ...
By offering tailored solutions in pharmacodynamics, pharmacokinetics, toxicology, and consistency evaluation, we endeavors to addresses the multifaceted challenges faced by veterinarians and researchers,” said the Marketing Chief of CD Formulation. ...
However, with the launch of efficacy evaluation services by CD Formulation, researchers can now more accurately assess the bioavailability and pharmacokinetics of oral thin films. By utilizing a combination of cutting-edge analytical techniques, CD Formulation is able to analyze the drug release kinetics, bioavailability, and pharmacokinetics of oral thin films ...
Biopharma PEG's latest offerings provide unparalleled options for ADC linkers, enabling pharmaceutical companies to modulate the physicochemical, pharmacodynamic, and pharmacokinetic properties of their ADCs with precision.Dr. Deng, Director of Research and Development at Biopharma PEG, expressed enthusiasm about the transformative potential of these monodispersed PEGs. ...
Through its expertise in various cutting-edge technologies such as microneedle and thin film technologies, transdermal patches, microencapsulation, and nanoparticle development, CD Formulation is revolutionizing the way drugs are delivered to patients, ultimately improving pharmacokinetics and pharmacodynamics. One of the key areas of focus for CD Formulation is its Novel Drug ...
In Clinical trials, R-PE labeled proteins can be used for dynamic monitoring of drugs and pharmacokinetic studies. With a complete, professional, as well as an experienced team, Creative BioMart now offers over 300 kinds of R-PE or APC conjugated recombinant proteins which are convenient for research assay. ...
With a commitment to quality and excellence, Alfa Chemistry offers pharmacological analysis, drug safety evaluation, pharmacokinetic analysis, and bioanalytical services to streamline the drug development process and ensure the safety and efficacy of potential new therapeutics. ...
These conjugates of siRNAs like GalNAc-siRNA conjugates and antibody-siRNA conjugates exhibit improved characteristics in terms of pharmacokinetics, cellular absorption, specificity towards the target, and safety. ...
Peptide-drug conjugates (PDCs) are mainly used in anti-cancer therapy, which integrates the advantages of small molecular weight, high tumor penetration, low immunogenicity, large-scale synthesis using solid phase synthesis, low production cost, relatively good pharmacokinetics, and so on. Peptides selected for PDCs can specifically target protein receptors overexpressed in tumor ...
A focus of the presentation will be on the target engagement results and pharmacokinetics from its ongoing monotherapy dose-escalation study to explore a potential optimal dose and schedule to effectively inhibit AhR. ...
ByBayer AG
“In the beginning, people may view pharmaceutical analysis as analytical chemistry dealing with drug substances and pharmaceutical products, but in fact, analytical chemists are involved in many more studies, including the analysis of the chiral purity and quality of pharmaceutical formulations, drug quality control as well as pharmacokinetic studies,” the Marketing ...
Gadoquatrane A randomized, 4 x 4 cross-over study to investigate the dose-response of the new high relaxivity GBCA gadoquatrane in comparison to the standard dose of gadobutrol This dose-response MRI study investigated the signal enhancement properties as well as pharmacokinetics and safety of the novel tetrameric macrocyclic GBCA gadoquatrane at various dose levels. ...
ByBayer AG
In these positions he was responsible for the Discovery, Pharmacology, Toxicology and DMPK (Drug Metabolism & Pharmacokinetics) activities in close collaboration with CMC (chemistry, manufacturing, control), Clinical Development as well as Regulatory Affairs ensuring smooth and successful project transition from research into early and late-stage clinical development. ...
“Tulmimetostat was designed to target both EZH2-related tumor progression and the redundant actions of EZH1 with high potency and durability, along with additional pharmacokinetic advances over prior EZH2 inhibitors, offering the potential for enhanced anti-tumor activity across numerous cancer types,” said Tim Demuth, M.D., Ph.D., MorphoSys Chief Research and ...
Currently, enkephalins are limited in their therapeutic potential by their pharmacokinetic profiles due to their inability to cross the blood-brain barrier to reach opioid receptors located in the central nervous system. ...
All subjects tolerated the LP-10 instillations and completed the study without report of product-related serious adverse events. LP-10 pharmacokinetic analysis demonstrated short duration of systemic uptake, decreased cystoscopic bleeding and ulceration sites, and improved patients’ urinary symptoms. ...